ARYx Therapeutics, Inc.
ARYX · OTC
12/31/2009 | 12/31/2008 | 12/31/2007 | 12/31/2006 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$33 | -$31 | -$28 | -$27 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2 | $0 | $0 | $0 |
| Change in WC | -$5 | -$18 | -$2 | $21 |
| Other Non-Cash | $0 | $2 | $1 | $1 |
| Operating Cash Flow | -$35 | -$45 | -$28 | -$4 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$1 | -$0 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$11 | -$17 | -$21 | -$69 |
| Inv. Sales/Matur. | $20 | $15 | $45 | $52 |
| Other Inv. Act. | $0 | -$0 | -$0 | $0 |
| Investing Cash Flow | $8 | -$2 | $23 | -$19 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$3 | $8 | -$3 | -$1 |
| Stock Issued | $1 | $20 | $44 | $30 |
| Stock Repurch. | -$0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | -$2 | $28 | $41 | $29 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$29 | -$19 | $37 | $6 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $36 | $55 | $19 | $12 |
| End Cash | $7 | $36 | $55 | $19 |
| Free Cash Flow | -$35 | -$46 | -$28 | -$5 |